glp 1 and sglt2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys the Brain Renal outcomes of SGLT2 inhibitors

Researchers are beginning to link these tiny creatures to all sorts of health conditions from obesity to neurodegenerative diseases

Our job is to present the facts about the different tools and strategies our clients can use to get from where they are to where they want to go

doi: 10.1016/j.bcab.2021.102023 23 BelkacemN.SerafiniN.WheelerR.DerrienM.BoucinhaL.CouesnonA.et al

The benefits are comparable or superior to the benefits of GLP-1 drugs, including dramatic weight loss and secondary long-term health benefits, such as improved blood sugar levels

Give your body a clear signal to keep its muscle and build a routine that sticks